Production (Stage)
EGF Theramed Health Corp.
EVAHF
$0.026
-$0.021-44.68%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | 2.30K | -- |
| Gross Profit | -- | -- | -- | -2.30K | -- |
| SG&A Expenses | 39.20K | 48.00K | 23.40K | 63.00K | 33.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.20K | 48.00K | 23.40K | 65.30K | 33.20K |
| Operating Income | -39.20K | -48.00K | -23.40K | -65.30K | -33.20K |
| Income Before Tax | -52.20K | -154.00K | -29.30K | -81.40K | -54.80K |
| Income Tax Expenses | -- | 3.10K | -- | -- | -- |
| Earnings from Continuing Operations | -52.20K | -157.10K | -29.30K | -81.40K | -54.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.50K | 15.00K | 1.30K | 6.20K | 7.30K |
| Net Income | -48.70K | -142.10K | -27.90K | -75.30K | -47.50K |
| EBIT | -39.20K | -48.00K | -23.40K | -65.30K | -33.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 11.62M | 11.62M | 11.54M | 11.39M | 11.39M |
| Average Diluted Shares Outstanding | 11.62M | 11.62M | 11.54M | 11.39M | 11.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |